Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: ValuEngine, Inc.
$25.00
Provider: Reuters Investment Profile
$20.00
Provider: Ford Investor Services, Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

PTC Therapeutics Inc announces proposed public offering of common stock


Monday, 10 Feb 2014 04:13pm EST 

PTC Therapeutics Inc:Commences an underwritten public offering of about $75 million of shares of its common stock.Says number of shares to be offered and the price for the proposed offering have not yet been determined.Says all of the shares in the offering are to be sold by PTC. PTC intends to grant the underwriters a 30-day option to purchase up to an additional 15 percent of the shares of common stock sold in the offering.Says offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed.J.P. Morgan and Credit Suisse are acting as joint lead book-running managers for the offering. 

Company Quote

26.42
-2.57 -8.87%
31 Jul 2014